In this study, we have shown that CA XII is frequently expressed in invasive breast carcinoma, where expression is strongly associated with several good prognostic parameters, including low tumour grade, ER-positive status, EGFR-negative status, and absence of necrosis. The gene discussed is ESR1; the disease is invasive breast carcinoma.